| LZSMX | PRIDX | LZSMX / PRIDX | |
| Total Expense Ratio | 1.28 | 1.24 | 103% |
| Annual Report Gross Expense Ratio | 2.50 | 1.24 | 202% |
| Fund Existence | 29 years | 37 years | - |
| Gain YTD | 9.501 | 5.110 | 186% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.3M | 6.44B | 0% |
| Annual Yield % from dividends | 1.52 | 1.25 | 122% |
| Returns for 1 year | 41.90 | 24.08 | 174% |
| Returns for 3 years | 45.74 | 33.45 | 137% |
| Returns for 5 years | -8.55 | -13.63 | 63% |
| Returns for 10 years | 30.14 | 71.18 | 42% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBDIX | 168.06 | 2.02 | +1.22% |
| Franklin Biotechnology Discovery A | |||
| JDCAX | 54.33 | 0.16 | +0.30% |
| Janus Henderson Forty A | |||
| EMRYX | 18.80 | 0.03 | +0.16% |
| VanEck Emerging Markets Y | |||
| GEMAX | 30.88 | 0.03 | +0.10% |
| Goldman Sachs Emerging Markets Eq A | |||
| GGSOX | 16.73 | -0.02 | -0.12% |
| Grandeur Peak Global Stalwarts Investor | |||